KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹37 Cr | ₹32 Cr | ₹24 Cr | ₹18 Cr | ₹11 Cr |
What is the latest Operating Profit of KILITCH DRUGS (INDIA) ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹37 Cr |
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹11 Cr |
How is Operating Profit of KILITCH DRUGS (INDIA) Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹37 Cr | 17.59 | |
| Mar2025 | ₹32 Cr | 30.84 | |
| Mar2024 | ₹24 Cr | 36.84 | |
| Mar2023 | ₹18 Cr | 68.82 | |
| Mar2022 | ₹11 Cr | - | |
Compare Operating Profit of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹722.1 Cr | -0.9% | -3.9% | 8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -0.9% |
-3.9% |
8.7% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses